Insights on the role of PSMA PET imaging for the correct re-classification of PCa have emerged, aiding the correct framing of patients from low- and intermediate-risk to high-risk neoplasm, a change that can influence the prognosis of these subjects. This evidence concerns the gene FOLH1 and neoplasm.